Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore complex-interacting protein family member A1 (NPIPA1) is a protein coding gene in humans, part of a family not considered to form the core structure of the nuclear pore complex but predicted to participate in mRNA and protein transport across the nuclear envelope. It is located at the nuclear membrane and is thought to be involved in nucleocytoplasmic transport. NPIPA1 has been associated with autism spectrum disorder, but there are no known drugs targeting this protein and it is not recognized as a therapeutic target or classical receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex-interacting protein family member A1 (NPIPA1).